InvestorsHub Logo
Followers 32
Posts 2200
Boards Moderated 0
Alias Born 09/01/2020

Re: None

Monday, 12/21/2020 5:33:12 PM

Monday, December 21, 2020 5:33:12 PM

Post# of 701136
AF and his buddies have been bashing Cytodyn (CYDN) for quite some time because their therapy, if approved, would hurt Gilead’s Remdesivir penetration. Most medical doctors and in fact even WHO recommends against the use of Remdesivir, but FDA hasn’t taken away their EUA. Just shows how much influence some of these big pharmas, particularly Gilead, has on FDA. What a shame! Anyway, look at CYDY’s performance this month. It has more than doubled and investors are showing confidence in the fact that science is going to validate when they unblind their results of the COVID severe to critical patients towards end of next month. AF has no credibility left, and he will be proven wrong again with NWBO when we announce ground breaking results! :)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News